Bioprinted Cartilage Graft
Patient-matched cartilage for joint and airway repair, printed from autologous chondrocytes. Cartilage is avascular, so the graft needs no built-in blood supply — the honest place to start. First-in-human trials underway.

Segal Health applies the Segal engineering discipline to the hardest frontier of all — the human body. We print replacement organs, regrow tissue from a patient's own cells, and manufacture the molecules that sharpen the mind. Designed, fabricated, and delivered, under one roof.
Three divisions share a single biofabrication core: Regenerative bioprints replacement organs and body parts, Longevity runs stem-cell research for life extension, and Neuropharm manufactures GMP-grade neuropharmaceuticals. One algorithm — resolve, design, fabricate, validate, deliver — applied to different biological feedstock.
Autonomous 3D bioprinting of replacement organs and body parts. We image a patient, model the structure, and print living tissue from their own cells — ending the donor waitlist and the rejection that follows it.
Stem-cell research for human life extension. We reprogram and deploy a patient's own cells to repair tissue, reset biological age markers, and treat the diseases of aging at their cellular root rather than their symptoms.
Precision pharmaceutical manufacturing for the mind. GMP-grade stimulants and psychedelic compounds — for focus, and for the treatment of depression, PTSD, and addiction — made to a purity and consistency the clinic can trust.
Prints sacrificial channels that are later dissolved and endothelialized into a perfusable network — the prerequisite for keeping solid organs alive beyond the ~200µm oxygen diffusion limit.
Applies reprogramming factors transiently and cyclically to roll back epigenetic age while preserving cell identity. Full reprogramming is deliberately avoided — it risks loss of function and teratoma.
Produces CNS-active compounds under ICH-aligned GMP with documented in-process controls and batch release. Vertical integration keeps identity, potency, and purity under one roof.
Patient-matched cartilage for joint and airway repair, printed from autologous chondrocytes. Cartilage is avascular, so the graft needs no built-in blood supply — the honest place to start. First-in-human trials underway.
A vascularized kidney construct printed around a sacrificial channel network, feeding tissue past the ~200µm diffusion limit — the path off dialysis and the transplant list. Pre-clinical.
Partial reprogramming of patient-derived cells to reset epigenetic age markers without erasing identity, then returned to repair tissue. Beginning with the eye and immune system. Pre-clinical.
Single-enantiomer stimulant therapeutics for ADHD and focus, synthesized on GMP lines and released only after identity, potency, and chiral-purity testing. Supplied to licensed clinical partners.
Standardized, analytically-pure psilocybin for treatment-resistant depression and PTSD. Consistency is the therapeutic variable, so purity is the deliverable. Supplied to authorized trial sites under chain-of-custody.
Orbital systems and launch. Space infrastructure and exploration.
Autonomous aircraft and airships.
Maritime hulls and offshore systems.
Cross-domain defense systems.
Quantum intelligence and analytics.
Autonomous robotics.
The operating system for the network.
Hardware and components.
Sustainable energy.
Advanced manufacturing.
Food and land systems.
Every part, one keystroke away.
Story and signal.
Real assets and infrastructure.